Private Equity Wire speaks to Ian Connatty, managing director of funds at British Patient Capital. The conversation centred around BPC´s new GBP375 million ‘Future Fund: Breakthrough,’ how it aims to accelerate the growth of R&D-intensive businesses, and the recent growth of unicorns in the UK and Europe.
Private Equity Wire speaks to Ian Connatty, managing director of funds at British Patient Capital. The conversation centred around BPC´s new GBP375 million ‘Future Fund: Breakthrough,’ how it aims to accelerate the growth of R&D-intensive businesses, and the recent growth of unicorns in the UK and Europe.
